Table 1.

Patient characteristics, treatment, clinical outcome, and tumor characterization

Patient	Age	Breed	Gender	CAV vacc.	dCelyvir doses	RAVNO	Tumor location	Diagnosis
1	8	French Bulldog	M	8	8	PD	Temp.	Olig. III
2	6	French Bulldog	M	3	11	PD	Frontal	Olig. III
3	7	Poodle	M	1	8	PR	Temp.+Occ.	Olig. III
4	9	English Bulldog	F	11	1	N/A	Temp.+Th.	N/A
5	9	Boxer	F	35	12	SD	Frontal	Olig. III
6	9	Boxer	M	5	14	SD	Frontal	GBM
7	10	French Bulldog	M	4	12	SD	Frontal+Th.	GBM
8	6	French Bulldog	M	5	5	N/A	Frontal+parietal + Temp.+Th.	Olig. III
9	8	French Bulldog	F	10	17	PR	Parietal+Th.	N/A
10	6	French Bulldog	M	3	4	N/A	Frontal	Olig. III

Age in years; CAV vaccination in months.

CAV, canine adenovirus; F, female; GBM, glioblastoma multiforme; M, male; N/A, not available; Occ., Occipital; Olig. III, oligodendroglioma grade III; PD, progressive disease; PR, partial response; RAVNO, response assessment in veterinary neuro-oncology; SD, stable disease; Temp., temporal; Th., thalamus.